Home > Insider Trading > Filing (0001209191-17-025700)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610876	Jeffrey Chodakewitz	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp Gmda, Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-04-03	2,291	$73.51	124,802	No	4	M	Direct
Common Stock	Disposition	2017-04-03	1,491	$108.50	123,311	No	4	S	Direct
Common Stock	Disposition	2017-04-03	600	$109.32	122,711	No	4	S	Direct
Common Stock	Disposition	2017-04-03	200	$110.09	122,511	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-04-03	2,291	$0.00	2,291	$73.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,334		2024-01-01	No	4	M	Direct

Footnotes

Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1.
Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $108.50 (range $108.07 to $108.84).
Open market sales reported on this line occurred at a weighted average price of $109.32 (range $109.09 to $109.70).
The option vests in 16 quarterly installments from 01/02/2014.